Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T23:06:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The 403 page content and related HTML were removed, suggesting the study details page now renders normally and presents the trial information and related navigation.
    Difference
    0.5%
    Check dated 2026-09-29T23:00:44.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content (including documents and details), replacing the previously accessible trial information with an access-restricted view.
    Difference
    17%
    Check dated 2026-09-22T23:17:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.7.0, replacing Revision: v3.6.6. This indicates an update to the page's version metadata rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-15T21:40:32.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, signaling a minor update to the record; the previous revision v3.6.5 is superseded by the new version.
    Difference
    0.1%
    Check dated 2026-09-01T18:17:40.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a platform-level update. No study content or visible information appears to have changed.
    Difference
    0.1%
    Check dated 2026-08-11T17:11:13.000Z thumbnail image

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.